Clinical Trial Update: Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing tolerability and potential clinical benefit of fecal microbiota transplantation in patients with melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Melanoma | Phase 2 | Status: COMPLETED